Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Learning to fly with broken wings - forcing a reappraisal of time and space.
Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
EAE is not a useful model for demyelinating disease.
Acute Disseminated Encephalomyelitis.
Impaired toll-like receptor 8 signaling in multiple sclerosis.
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Seizure characteristics in multiple sclerosis patients.
Human neural stem cells induce functional myelination in mice with severe dysmyelination.
Neuroimaging of dementia.
Aquaporin and brain diseases.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
The story of neuromyelitis optica continues to be written.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Disruption of structural and functional networks in long-standing multiple sclerosis.
Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up.
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems.
Functional brain imaging: an evidence-based analysis.
Longitudinal Change in Physical Activity and Its Correlates in Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
393
394
395
396
397
398
399
400
401
…
next ›
last »
